Global and Region Interventional X-ray Contrast and Imaging Agents Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging.

    The report details the trend, potential and market size of Interventional X-ray Contrast and Imaging Agents market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Interventional X-ray Contrast and Imaging Agentsmarket, defines the market attractiveness level of Interventional X-ray Contrast and Imaging Agents market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Interventional X-ray Contrast and Imaging Agents industry, describes the types of Interventional X-ray Contrast and Imaging Agents market, the applications of major players and the market size, and deeply analyzes the current situation of the global Interventional X-ray Contrast and Imaging Agents market and the development prospects and opportunities of Interventional X-ray Contrast and Imaging Agents industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Interventional X-ray Contrast and Imaging Agents market in Chapter 13.

    By Player:

    • Guerbet

    • Novalek Pharmaceuticals

    • Nano Therapeutics

    • Lantheus Medical Imaging

    • General Electric

    • Unijules Life Sciences

    • Taejoon Pharm

    • Imax

    • Jodas Expoim

    • Fujifilm Visualsonics

    • JB Chemicals & Pharmaceuticals

    • Bracco

    By Type:

    • Iodinated Contrast Media

    • Barium-Based Contrast Media

    • Microbubble Contrast Media

    • Other

    By End-User:

    • Heart Disease

    • Neurological

    • Urology

    • General Surgery

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Interventional X-ray Contrast and Imaging Agents Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Interventional X-ray Contrast and Imaging Agents Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Interventional X-ray Contrast and Imaging Agents Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Interventional X-ray Contrast and Imaging Agents Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Interventional X-ray Contrast and Imaging Agents Market Analysis and Outlook to 2022

    • 7.1 Global Interventional X-ray Contrast and Imaging Agents Consumption (2017-2022)

    • 7.2 United States Interventional X-ray Contrast and Imaging Agents Consumption (2017-2022)

    • 7.3 Europe Interventional X-ray Contrast and Imaging Agents Consumption (2017-2022)

    • 7.4 China Interventional X-ray Contrast and Imaging Agents Consumption (2017-2022)

    • 7.5 Japan Interventional X-ray Contrast and Imaging Agents Consumption (2017-2022)

    • 7.6 India Interventional X-ray Contrast and Imaging Agents Consumption (2017-2022)

    • 7.7 South Korea Interventional X-ray Contrast and Imaging Agents Consumption (2017-2022)

    8 Region and Country-wise Interventional X-ray Contrast and Imaging Agents Market Analysis and Outlook to 2028

    • 8.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast (2022-2028)

    • 8.2 United States Interventional X-ray Contrast and Imaging Agents Consumption Forecast (2022-2028)

    • 8.3 Europe Interventional X-ray Contrast and Imaging Agents Consumption Forecast (2022-2028)

    • 8.4 China Interventional X-ray Contrast and Imaging Agents Consumption Forecast (2022-2028)

    • 8.5 Japan Interventional X-ray Contrast and Imaging Agents Consumption Forecast (2022-2028)

    • 8.6 India Interventional X-ray Contrast and Imaging Agents Consumption Forecast (2022-2028)

    • 8.7 South Korea Interventional X-ray Contrast and Imaging Agents Consumption Forecast (2022-2028)

    9 Global Interventional X-ray Contrast and Imaging Agents Market Outlook by Types and Applications to 2022

    • 9.1 Global Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Barium-Based Contrast Media Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Heart Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Neurological Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Urology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global General Surgery Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Interventional X-ray Contrast and Imaging Agents Market Outlook by Types and Applications to 2028

    • 10.1 Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Barium-Based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Neurological Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Urology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global General Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Interventional X-ray Contrast and Imaging Agents Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Interventional X-ray Contrast and Imaging Agents Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Interventional X-ray Contrast and Imaging Agents Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Interventional X-ray Contrast and Imaging Agents Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Interventional X-ray Contrast and Imaging Agents Market Competitive Analysis

    • 14.1 Guerbet

      • 14.1.1 Guerbet Company Details

      • 14.1.2 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Guerbet Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.2 Novalek Pharmaceuticals

      • 14.2.1 Novalek Pharmaceuticals Company Details

      • 14.2.2 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.3 Nano Therapeutics

      • 14.3.1 Nano Therapeutics Company Details

      • 14.3.2 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.4 Lantheus Medical Imaging

      • 14.4.1 Lantheus Medical Imaging Company Details

      • 14.4.2 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.5 General Electric

      • 14.5.1 General Electric Company Details

      • 14.5.2 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 General Electric Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.6 Unijules Life Sciences

      • 14.6.1 Unijules Life Sciences Company Details

      • 14.6.2 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.7 Taejoon Pharm

      • 14.7.1 Taejoon Pharm Company Details

      • 14.7.2 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.8 Imax

      • 14.8.1 Imax Company Details

      • 14.8.2 Imax Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Imax Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.9 Jodas Expoim

      • 14.9.1 Jodas Expoim Company Details

      • 14.9.2 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.10 Fujifilm Visualsonics

      • 14.10.1 Fujifilm Visualsonics Company Details

      • 14.10.2 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.11 JB Chemicals & Pharmaceuticals

      • 14.11.1 JB Chemicals & Pharmaceuticals Company Details

      • 14.11.2 JB Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 JB Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product and Service

    • 14.12 Bracco

      • 14.12.1 Bracco Company Details

      • 14.12.2 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Bracco Interventional X-ray Contrast and Imaging Agents Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Interventional X-ray Contrast and Imaging Agents

    • Figure Interventional X-ray Contrast and Imaging Agents Picture

    • Table Global Interventional X-ray Contrast and Imaging Agents Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Interventional X-ray Contrast and Imaging Agents Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Interventional X-ray Contrast and Imaging Agents Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Interventional X-ray Contrast and Imaging Agents Consumption by Country (2017-2022)

    • Figure United States Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2017-2022)

    • Table Europe Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2017-2022)

    • Figure China Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2017-2022)

    • Figure Japan Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2017-2022)

    • Figure India Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2017-2022)

    • Figure South Korea Interventional X-ray Contrast and Imaging Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Interventional X-ray Contrast and Imaging Agents Consumption Forecast by Country (2022-2028)

    • Figure United States Interventional X-ray Contrast and Imaging Agents Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Interventional X-ray Contrast and Imaging Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Interventional X-ray Contrast and Imaging Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Interventional X-ray Contrast and Imaging Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Interventional X-ray Contrast and Imaging Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Interventional X-ray Contrast and Imaging Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Barium-Based Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Neurological Consumption and Growth Rate (2017-2022)

    • Figure Global Urology Consumption and Growth Rate (2017-2022)

    • Figure Global General Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Barium-Based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurological Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global General Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Interventional X-ray Contrast and Imaging Agents Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Interventional X-ray Contrast and Imaging Agents Export by Region (Top 5 Countries) (2017-2028)

    • Table Guerbet (Foundation Year, Company Profile and etc.)

    • Table Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guerbet Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table Novalek Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table Nano Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table Lantheus Medical Imaging (Foundation Year, Company Profile and etc.)

    • Table Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table General Electric (Foundation Year, Company Profile and etc.)

    • Table General Electric Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table General Electric Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table Unijules Life Sciences (Foundation Year, Company Profile and etc.)

    • Table Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table Taejoon Pharm (Foundation Year, Company Profile and etc.)

    • Table Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table Imax (Foundation Year, Company Profile and etc.)

    • Table Imax Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Imax Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table Jodas Expoim (Foundation Year, Company Profile and etc.)

    • Table Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table Fujifilm Visualsonics (Foundation Year, Company Profile and etc.)

    • Table Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table JB Chemicals & Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table JB Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table JB Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product and Service

    • Table Bracco (Foundation Year, Company Profile and etc.)

    • Table Bracco Interventional X-ray Contrast and Imaging Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Interventional X-ray Contrast and Imaging Agents Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.